Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 441460 of 20,252 grants

Active NON-SBIR/STTR RPGS
Project 2: BRCA1-dependent DNA End Resection and Regulation via the 53BP1 Axis
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT DNA double strand breaks (DSBs) are induced by genotoxic agents such as ionizing radiation, chemotherapeutic agents, and during encounters of the DNA repli...

Active NON-SBIR/STTR RPGS
Redefining indications of EGFR inhibitors in cancers that harbor mutant RAS
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2024 – 2029

Background: Anti-EGFR agents have been shown to benefit colorectal cancer patients, except for patients whose tumor includes a KRAS mutation. Data from multiple clinical trials sug...

$3.57M
USD
Active NON-SBIR/STTR RPGS
Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

SUMMARY Chemotherapy induced peripheral neuropathy (CIPN) is the most prevalent neurological complication of oral or intravenous chemotherapy. Approximately 50–90% of patients unde...

$6.61M
USD
Active NON-SBIR/STTR RPGS
The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy
NATIONAL CANCER INSTITUTE University of Texas Med Br Galveston United States 2024 – 2029

Project summary/Abstract: Paclitaxel-induced peripheral neuropathy (PIPN) and associated neuropathic pain is a significant adverse effect experienced by cancer patients who receive...

$4.03M
USD
Active TRAINING, INDIVIDUAL
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NATIONAL CANCER INSTITUTE Boston University (Charles River Campus United States 2024 – 2026

PROJECT SUMMARY Multiple myeloma is the second most prevalent hematologic malignancy in the US with an estimated 7.1 cases per 100,000. Patients diagnosed with multiple myeloma hav...

$386.5K
USD
Active TRAINING, INDIVIDUAL
The role of mesothelial-derived cancer-associated fibroblasts in the pathogenesis of pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2028

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDA) is a deadly disease with a five-year survival rate of 12%. Oncogenic KRAS (Kras*) is a near-universal driver of PDA, and its...

$473.4K
USD
Active NON-SBIR/STTR RPGS
Mechanisms of endocrine therapy and radiation synergism to decrease brain metastases
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

PROJECT SUMMARY The increasing number of young women diagnosed with metastatic breast cancer has awakened the urgency to define why they are more likely to suffer from aggressive b...

$5.18M
USD
Active TRAINING, INDIVIDUAL
Defining the Mechanistic Impact of PRC1 Overexpression on Mammalian Spindle Mechanics
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2027

Project Summary/Abstract Errors in chromosome segregation lead to aneuploidy, a hallmark of cancer. While we know nearly all molecules involved in mammalian cell division, we do no...

$414.9K
USD
Active TRAINING, INDIVIDUAL
Characterizing Oncogenic Nras in IDH1 Mutant AML Leukemogenesis and Therapeutic Responsiveness
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Acute Myeloid Leukemia (AML) is a lethal hematologic malignancy characterized by impaired myeloid differentiation and blast proliferation, inhibiting norma...

$539.7K
USD
Active TRAINING, INDIVIDUAL
Investigating the role of FOXA1/2 and HNF4⍺ in Pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2027

PROJECT ABSTRACT Cell identity, crucially controlled by transcription factors (TFs), is perturbed in cancer, contributing to highly aggressive and metastatic tumors, such as pancre...

$422.5K
USD
Active OTHER RESEARCH-RELATED
Harnessing human gut-derived Bacteroides to drive systemic anti-tumor immunity
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

Although immune checkpoint blockade has transformed therapeutic options for lung cancer, its efficacy differs widely even between patients with remarkably similar disease, and whil...

$2.82M
USD
Active OTHER RESEARCH-RELATED
Improving the Assessment of Patient-reported Outcomes among Black/African-American Cancer Patients
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Project Summary Willi L. Tarver is an Assistant Professor in the Division of Cancer Prevention and Control, College of Medicine at The Ohio State University. Dr. Tarver is respondi...

$1.62M
USD
Active OTHER RESEARCH-RELATED
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2029

Title: Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapy Abstract Immune checkpoint inhibitors (IC...

$2.35M
USD
Active NON-SBIR/STTR RPGS
Towards a Comprehensive, Spatiotemporal Roadmap of Cancer Metastasis
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2027

PROJECT SUMMARY Cancer metastasis, which accounts for 8 million deaths worldwide annually, is a multistep process that includes the emergence of metastatic subclones in primary tum...

$14.81M
USD
Active NON-SBIR/STTR RPGS
Defining the landscape of bacterial-colonized microniches in tumors and their role in intratumoral heterogeneity.
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Within a patient’s tumor, malignant cells are surround by a complex and dynamic collection of cell types, which includes the intratumoral microbiota. Howev...

$6.27M
USD
Active NON-SBIR/STTR RPGS
Social Genomic Mechanisms Linking Structural Racism, Perceived Discrimination, and Breast Cancer Survival
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT SUMMARY Women living in historically redlined neighborhoods impacted by structural racism and discrimination (SRD) have shorter breast cancer (BCa) recurrence-free survival...

$5.83M
USD
Active NON-SBIR/STTR RPGS
Evolved Molecules that Destroy Cancer Relevant Proteins
NATIONAL CANCER INSTITUTE Foundation for Applied Molecular Evolutn United States 2024 – 2027

ABSTRACT Cancer research is often driven by hypotheses that postulate that a specific protein is important for the disease, hypotheses often tested by adding an antibody to that sy...

$2.16M
USD
Active NON-SBIR/STTR RPGS
Resolving transcription factor target search mechanisms
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2024 – 2029

Project Summary Proper gene expression regulation is pivotal for cellular function, and its dysregulation contributes to disease. Transcription factors (TFs) initiate gene expressi...

$5.88M
USD
Active NON-SBIR/STTR RPGS
Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism
NATIONAL CANCER INSTITUTE Boston University (Charles River Campus United States 2024 – 2027

Project Summary Understanding how cancer cells reprogram their metabolism and interact with other biological processes to gain aggressiveness and/or resistance to a treatment is of...

$4.07M
USD
Active NON-SBIR/STTR RPGS
Quantification of molecular interactions across the matrix spectrum enables cancer research.
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2027

Project Summary We propose to further develop, refine, and validate our emerging free-solution assay (FSA) technology and our relatively new compensated Interferometric reader (CIR...

$3.36M
USD